Alpha Teknova (Alpha Teknova) ROCE % : -27.83% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Teknova ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Alpha Teknova's annualized ROCE % for the quarter that ended in Dec. 2023 was -27.83%.

Alpha Teknova ROCE % Historical Data

The historical data trend for Alpha Teknova's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Teknova ROCE % Chart

Alpha Teknova Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-3.51

8.34

-11.03

-19.23

-23.90

Alpha Teknova Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial												-27.78	-26.14	-16.26	-29.96	-27.83

Alpha Teknova ROCE % Calculation

Alpha Teknova's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-31.199	/	( ( (152.261 - 10.875)	+	(128.587 - 8.875) )	/ 2 )
	=	-31.199	/	( (141.386	+	119.712)	/ 2 )
	=	-31.199	/	130.549
	=	-23.90 %

Alpha Teknova's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-34.756	/	( ( (138.385 - 8.339)	+	(128.587 - 8.875) )	/ 2 )
	=	-34.756	/	( ( 130.046	+	119.712 )	/ 2 )
	=	-34.756	/	124.879
	=	-27.83 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Alpha Teknova (NAS:TKNO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Alpha Teknova ROCE % Related Terms

Thank you for viewing the detailed overview of Alpha Teknova's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Teknova (Alpha Teknova) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpha Teknova Inc (NAS:TKNO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2451 Bert Drive, Hollister, CA, USA, 95023

Website

https://www.teknova.com

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.

Executives

Ken Gelhaus	officer: Chief Commercial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Stephen Gunstream	director, officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
J Matthew Mackowski	director	343 SANSOME ST, SUITE 1215, SANSASAN FRANCISCO CA 94104
Matthew Lowell	officer: Chief Financial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Damon Terrill	officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
Thp Iv Affiliates Fund, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108
Martha J Demski	director	7770 REGENTS ROAD SUITE 113-505, SAN DIEGO CA 92122
Lisa Hood	officer: Chief People Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Irene Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Ted Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Iv, L.p.	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO MA 94108
Paul David Grossman	director	1600 FARADAY AVENUE, CARLSBAD CA 92008
Brett Robertson	director	C/O INVUITY, INC., 444 DE HARO STREET, SAN FRANCOSCO CA 94107
Alexander C. Herzick	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Management Company, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108